IMUNON, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 USD | +1.53% |
|
-7.64% | +95.59% |
| 18/04 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
| 18/04 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Chart calendar Imunon, Inc.
2f5fe276dc89e9dae.UCUacpMzQqclF5G8I1zEDc9Kp52wLSZe-uf3Jm3p63E.KFNUFfBqO-58J8f7bWqwTqka7M3GGAscpbG_Ejjfjgc_fW41xwAY0U8i9g~e5097ae04bf086c78e492e63d7274001
Upcoming events on Imunon, Inc.
Past events on Imunon, Inc.
| 28/03/2024 07:30 pm | Q4 2023 Earnings Call |
| 28/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 14/11/2023 08:30 pm | Q3 2023 Earnings Call |
| 14/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 23/10/2023 11:30 pm | Edition of International Vaccines Congress |
| 15/09/2023 01:30 am | R&D Day |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 10/08/2023 08:30 pm | Q2 2023 Earnings Call |
| 10/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 14/06/2023 07:30 pm | Annual General Meeting |
| 13/06/2023 | Mass General Brigham World Medical Innovation Forum |
| 21/05/2023 | Viruses and Cells Gordon Research Conference |
| 11/05/2023 08:30 pm | Q1 2023 Earnings Call |
| 11/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 18/04/2023 06:30 pm | American Association for Cancer Research Meeting - Abstract No. 4440 |
| 30/03/2023 08:30 pm | Q4 2022 Earnings Call |
| 30/03/2023 05:30 pm | Q4 2022 Earnings Release |
| 21/03/2023 | Vaccine Technology Summit |
| 30/11/2022 | A.G.P.’s Virtual Biotech Conference |
| 14/11/2022 09:30 pm | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,50 0,51 -0.99% | 0,50 0,50 0% | 0,50 0,50 0% | 0,50 0,50 0% | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -20,6 -21,3 3.29% | -18,5 -18,1 -2.32% | -21,0 -21,1 0.4% | -24,9 -24,4 -1.98% | -21,0 -20,7 -1.62% | -22,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,7 -20,6 9.5% | -23,3 -23,3 -0.08% | -22,2 -22,2 0.14% | -37,5 -28,9 -29.6% | -20,8 -20,2 -3.17% | -23,0 |
|
Net income Million USD | Released Forecast Spread | -16,9 -19,6 13.92% | -21,5 -23,3 7.83% | -20,8 -22,2 6.38% | -35,9 -28,6 -25.48% | -19,5 -20,2 3.18% | -23,0 |
|
EPS USD | Released Forecast Spread | -11,5 -14,0 17.65% | -10,0 -10,9 8.22% | -3,83 -4,05 5.43% | -5,03 -4,19 -20.19% | -2,16 -2,23 3.28% | -2,27 |
| Announcement Date | 25/03/20 | 19/03/21 | 31/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,13 0,11 11.11% | 0,13 0,11 15.39% | 0,13 0,11 15.39% | 0,13 0,11 11.11% | 0,13 0,11 11.11% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,49 -5,58 1.67% | -5,84 -5,69 -2.66% | -5,98 -5,95 -0.53% | -6,17 -6,03 -2.47% | -6,93 -6,44 -7.55% | -5,68 -6,30 9.78% | -5,47 -6,27 12.73% | -3,90 -6,05 35.51% | -5,97 -5,61 -6.42% | -5,36 | -5,60 | -5,60 | -5,96 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,61 -5,58 -0.4% | -10,5 -5,85 -79.09% | -6,04 -5,92 -2.08% | -6,15 -6,00 -2.47% | -14,8 -6,29 -135.12% | -5,59 -6,30 11.25% | -5,56 -6,28 11.47% | -3,48 -6,13 43.25% | -6,17 -5,55 -11.18% | -5,43 | -5,77 | -5,63 | -6,10 |
|
Net income Million USD | Released Forecast Spread | -4,22 -5,58 24.39% | -10,5 -5,85 -79.09% | -6,04 -5,92 -2.08% | -6,15 -6,00 -2.47% | -13,2 -6,48 -104.24% | -5,59 -6,30 11.25% | -5,56 -6,28 11.47% | -3,48 -6,13 43.25% | -4,89 -5,55 11.9% | -5,43 | -5,77 | -5,63 | -6,10 |
|
EPS USD | Released Forecast Spread | -3,62 -0,90 -302.22% | -1,82 -1,01 -81.09% | -0,87 -0,98 11.22% | -0,87 -0,81 -7.41% | -1,61 -0,84 -92.24% | -0,68 -0,69 1.45% | -0,61 -0,73 16.82% | -0,37 -0,66 43.94% | -0,52 -0,59 11.36% | -0,57 | -0,60 | -0,59 | -0,51 |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Imunon, Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMNN Stock
- Calendar Imunon, Inc.
